Table 1 Descriptive statistics of the entire data collected, including the total number of the patient collective, division into children/adolescents with and without SHCNs, and the p value of the Mann–Whitney U test
Total N/median/min/max | SHCNs group N/median/min/max | NSHCNs group N/median/min/max | p* | |
|---|---|---|---|---|
PAR pre treatment | 58/19/4/49 | 29/21/10/49 | 29/17/4/31 | 0.037 |
PAR post treatment | 58/2/0/41 | 29/6/1/41 | 29/0/0/8 | 0.000 |
PAR score reduction | 58/13.5/-2/33 | 29/11/-2/33 | 29/16/4/31 | 0.053 |
AC pre treatment | 58/7/1/10 | 29/9/4/10 | 29/5/1/10 | 0.000 |
AC post treatment | 58/2/1/10 | 29/3/1/10 | 29/1/1/6 | 0.000 |
AC score reduction | 58/4/0/9 | 29/4/0/9 | 29/4/0/7 | 0.838 |
Overall treatment time | 58/48/4/186 | 29/50/4/186 | 29/48/6/126 | 0.451 |
Number of appointments | 58/32.5/5/73 | 29/36/5/70 | 29/31/6/73 | 0.652 |
Number of moderate chair time appointments | 58/17/0/45 | 29/13/0/36 | 29/21/1/45 | 0.001 |
Number of considerable chair time appointments | 58/15.5/3/56 | 29/22/3/56 | 29/12/5/32 | 0.048 |
Age at treatment start | 58/11/3/18 | 29/11/3/15 | 29/12/6/18 | 0.028 |
Age at treatment end | 58/15/6/22 | 29/14/8/20 | 29/16/6/22 | 0.025 |